First Clinical Study of the Selective 5‐HT3 Antagonist, Granisetron (BRL 43694), in the Acute Treatment of Migraine Headache
- 20 May 1991
- journal article
- clinical trial
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 31 (5), 296-297
- https://doi.org/10.1111/j.1526-4610.1991.hed3105296.x